| 000 | 01427 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512170203.0 | ||
| 264 | 0 | _c19711110 | |
| 008 | 197111s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1016/s0041-008x(71)80012-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSolymoss, B | |
| 245 | 0 | 0 |
_aProtection by spironolactone and oxandrolone against chronic digitoxin or indomethacin intoxication. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cMar 1971 |
||
| 300 |
_a586-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDigitoxin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Antagonism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIndomethacin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aIntestinal Diseases _xchemically induced |
| 650 | 0 | 4 | _aJejunum |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
| 650 | 0 | 4 | _aMortality |
| 650 | 0 | 4 |
_aOxandrolone _xtherapeutic use |
| 650 | 0 | 4 |
_aProadifen _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 650 | 0 | 4 |
_aSpironolactone _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aUlcer _xchemically induced |
| 700 | 1 | _aToth, S | |
| 700 | 1 | _aVarga, S | |
| 700 | 1 | _aSelye, H | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 18 _gno. 3 _gp. 586-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0041-008x(71)80012-1 _zAvailable from publisher's website |
| 999 |
_c5570760 _d5570760 |
||